NGM Biopharmaceuticals Inc (NGM) has fallen 9.09% Friday In Premarket Trading

Friday, October 13, 2023 06:46 AM | InvestorsObserver Analysts

Mentioned in this article

NGM Biopharmaceuticals Inc (NGM) has fallen 9.09% Friday In Premarket Trading

NGM Biopharmaceuticals Inc (NGM) is down Friday morning, with the stock declining -9.09% in pre-market trading to 1. NGM's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 136 out of 146 industries, the stock ranks higher than 0% of stocks. NGM Biopharmaceuticals Inc has fallen 27.15% over the past month, closing at $1.31 on September 15. During this period of time, the stock fell as low as $1.05 and as high as $1.40. NGM has an average analyst recommendation of Strong Buy. The company has an average price target of $5.67.

NGM has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on NGM!

See Full NGM Report

NGM Biopharmaceuticals Inc has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 138 by this metric, NGM ranks better than 138% of stocks.

Important Dates for Investors in NGM:

-NGM Biopharmaceuticals Inc is set to release earnings on 2023-11-02. Over the last 12 months, the company has reported EPS of $-2.06. -We do not have a set dividend date for NGM Biopharmaceuticals Inc at this time. Click Here To Get The Full Report on NGM Biopharmaceuticals Inc (NGM)